Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Histone H2B type 1-D (H2BC5) is a basic nuclear protein encoded by the intronless HIST1H2BD gene, found within the large histone gene cluster on chromosome 6p22-p21.3. It is a replication-dependent member of the histone H2B family, comprising part of the nucleosome core around which DNA is wrapped. Nucleosomes regulate accessibility of DNA to transcriptional machinery, contributing centrally to transcription regulation, DNA replication, repair, and chromosomal stability. Post-translational modifications of histones constitute a 'histone code' governing recruitment of transcription factors and chromatin-remodeling complexes. Dysregulated histone expression and modification are linked to cancer and other diseases; in particular, some evidence suggests association of H2BC5 with glioma susceptibility and hematologic cancers
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Histone H2B type 1-D (H2BC5).